Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Coley Pharmaceutical Group, Inc. (now Pfizer)

Acquired by Pfizer in 2007, Coley Pharmaceuticals is a biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates. Coleyis an important component of Pfizer's vaccine strategy and reflects their commitment to research new and more effective vaccines to prevent infectious diseases and to treat cancers and other debilitating conditions.

Search Projects

  • Vice President, Clinical Development
  • Director, Clinical Data Management